Clinical trial
Pravastatin and Protease Inhibitors in HIV-Infected Patients
NCT00221754 · University Hospital, Bordeaux, Other · Completed
Key facts
| NCT number | NCT00221754 |
|---|---|
| Title | Pravastatin and Protease Inhibitors in HIV-Infected Patients |
| Official title | Pravastatin in HIV-Infected Patients Treated With Highly Active Antiretroviral Therapy |
| Lead sponsor | University Hospital, Bordeaux, Other |
| Collaborators | Ministry of Health, France |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infection, Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Pravastatin (drug) |
| Enrollment | 21 |
| Start date | Mar 1, 2003 |
| Completion | Mar 1, 2004 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 13, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: